4//SEC Filing
Taylor Stacy L 4
Accession 0001209191-21-055367
CIK 0001478320other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 7:00 PM ET
Size
9.0 KB
Accession
0001209191-21-055367
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Sale
Common Stock
2021-09-07$40.00/sh−495$19,800→ 15,036 total - Exercise/Conversion
Common Stock
2021-09-07$6.55/sh+495$3,242→ 15,531 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-07−495→ 15,443 totalExercise: $6.55Exp: 2028-04-24→ Common Stock (495 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.
- [F2]The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001799081
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 7:00 PM ET
- Size
- 9.0 KB